Trial Profile
A study on efficacy and safety of Edoxaban on high-risk gastrointestinal endoscopic procedures
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2020
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Acronyms Edoxaban study
- 02 Mar 2020 Status changed from recruiting to discontinued.
- 08 Dec 2018 Status changed from not yet recruiting to recruiting.
- 09 Mar 2018 New trial record